Hepatitis B Vaccines
Open accessThe DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Abstract
Hepatitis B is caused by the hepatitis B virus (HBV), which infects the liver and may lead to chronic liver disease, including cirrhosis and hepatocellular carcinoma. HBV represents a worldwide public health problem, causing major morbidity and mortality. Affordable, safe, and effective, hepatitis B vaccines are the best tools we have to control and prevent hepatitis B. In 2019, coverage of 3 doses of the hepatitis B vaccine reached 85% worldwide compared to around 30% in 2000. The effective implementation of hepatitis B vaccination programs has resulted in a substantial decrease in the HBV carrier rate and hepatitis B-related morbidity and mortality. This article summarizes the great triumphs of the hepatitis B vaccine, the first anticancer and virus-like-particle–based vaccine. In addition, existing unresolved issues and future perspectives on hepatitis B vaccination required for global prevention of HBV infection are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G., & Ott, J. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61412-x · Cited by 2,742
Vaccine Adjuvants: Putting Innate Immunity to Work
Coffman, R. L., Sher, A., & Seder, R. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.002 · Cited by 1,924
Trépo, C., Chan, H. L. Y., & Lok, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60220-8 · Cited by 1,623
Hepatitis B virus.The major etiology of hepatocellular carcinoma
Beasley, R. P. (1988) · Cancer · doi:10.1002/1097-0142(19880515)61:10<1942::aid-cncr2820611003>3.0.co;2-j · Cited by 1,280
Mast, E. E., Weinbaum, C. M., Fiore, A. E., Alter, M. J., Bell, B. P., Finelli, L., Rodewald, L. E., Douglas, J. M., Janssen, R. S., & Ward, J. W. (2006) · PubMed · Cited by 1,259
Szmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Oleszko, W. R., William, D. C., Sadovsky, R., Morrison, J. M., & Kellner, A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010093031501 · Cited by 1,100
VIRUS-LIKE PARTICLES IN SERUM OF PATIENTS WITH AUSTRALIA-ANTIGEN-ASSOCIATED HEPATITIS
Dane, D. S., Cameron, C. H., & Briggs, M. (1970) · The Lancet · doi:10.1016/s0140-6736(70)90926-8 · Cited by 1,053
Liang, X., Bi, S., Yang, W., Wang, L., Cui, G., Cui, F., Zhang, Y., Liu, J., Gong, X., Chen, Y., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.048 · Cited by 982
Reagan-Steiner, S., Yankey, D., Jeyarajah, J., Elam-Evans, L. D., Singleton, J. A., Curtis, C. R., MacNeil, J., Markowitz, L. E., & Stokley, S. (2015) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6429a3 · Cited by 834
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
Weinbaum, C. M., Mast, E. E., & Ward, J. W. (2009) · Hepatology · doi:10.1002/hep.22882 · Cited by 815
Prevention and Control of Influenza: Recommendation of the Immunization Practices Advisory Committee
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-560 · Cited by 810
Parashar, U. (2006) · Medical Entomology and Zoology · Cited by 799
A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein, S. T., Zhou, F., Hadler, S. C., Bell, B. P., Mast, E. E., & Margolis, H. S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi206 · Cited by 743
Human hepatitis B vaccine from recombinant yeast
McAleer, W. J., Buynak, E. B., Maigetter, R. Z., Wampler, D. E., Miller, W. J., & Hilleman, M. R. (1984) · Nature · doi:10.1038/307178a0 · Cited by 739
Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual Men
Hadler, S. C., Francis, D. P., Maynard, J. E., Thompson, S. E., Judson, F. N., Echenberg, D. F., Ostrow, D. G., O'Malley, P. M., Penley, K. A., Altman, N. L., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607243150401 · Cited by 608
GYNAECOLOGISTS' ATTITUDES TO ABORTION
Savage, W., & Francome, C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91922-3 · Cited by 604
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
Pan, C. Q., Duan, Z., Dai, E., Zhang, S., Han, G., Wang, Y., Zhang, H., Zou, H., Zhu, B., Zhao, W., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1508660 · Cited by 573
Surveillance of Vaccination Coverage Among Adult Populations — United States, 2014
Williams, W. W., Lu, P.-J., O’Halloran, A., Kim, D. K., Grohskopf, L. A., Pilishvili, T., Skoff, T. H., Nelson, N. P., Harpaz, R., Markowitz, L. E., et al. (2016) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6501a1 · Cited by 500
Shouval, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00152-1 · Cited by 470
Hepatitis B Vaccine in Patients Receiving Hemodialysis: Immunogenicity and Efficacy
Stevens, C. E., Alter, H. J., Taylor, P. E., Zang, E. A., Harley, E. J., Szmuness, W., & the Dialysis Vaccine Trial Study Group (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110803 · Cited by 457
FRANCIS, D. P., HADLER, S. C., THOMPSON, S. E., MAYNARD, J. E., OSTROW, D. G., ALTMAN, N., BRAFF, E. H., O'MALLEY, P., HAWKINS, D., JUDSON, F. N., et al. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-362 · Cited by 428
The influence of age on the development of the hepatitis B carrier state
(1993) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1993.0102 · Cited by 424
Lee, C., Gong, Y., Brok, J., Boxall, E. H., & Gluud, C. (2006) · BMJ · doi:10.1136/bmj.38719.435833.7c · Cited by 402
Kowdley, K. V., Wang, C. C., Welch, S., Roberts, H., & Brosgart, C. L. (2012) · Hepatology · doi:10.1002/hep.24804 · Cited by 400
McQuillan, G. M., Coleman, P. J., Kruszon-Moran, D., Moyer, L. A., Lambert, S. B., & Margolis, H. S. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.1.14 · Cited by 376
West, D. (1996) · Vaccine · doi:10.1016/0264-410x(96)00062-x · Cited by 375
Requirements for global elimination of hepatitis B: a modelling study
Nayagam, S., Thursz, M., Sicuri, E., Conteh, L., Wiktor, S., Low-Beer, D., & Hallett, T. B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30204-3 · Cited by 373
Zanetti, A. R., Mariano, A., Romanò, L., D'Amelio, R., Chironna, M., Coppola, R. C., Cuccia, M., Mangione, R., Marrone, F., Negrone, F. S., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67568-x · Cited by 368
Conn, N., & Elias-Jones, T. F. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91808-5 · Cited by 368
Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China
Cui, F., Shen, L., Li, L., Wang, H., Wang, F., Bi, S., Liu, J., Zhang, G., Wang, F., Zheng, H., et al. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2305.161477 · Cited by 362
What Level of Hepatitis B Antibody Is Protective?
Jack, A. D., Hall, A. J., Maine, N., Mendy, M., & Whittle, H. C. (1999) · The Journal of Infectious Diseases · doi:10.1086/314578 · Cited by 354
Ni, Y., Huang, L., Chang, M., Yen, C., Lu, C., You, S., Kao, J., Lin, Y., Chen, H., Hsu, H., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.055 · Cited by 348
Stevens, C. E., Neurath, R. A., Beasley, R. P., & Szmuness, W. (1979) · Journal of Medical Virology · doi:10.1002/jmv.1890030310 · Cited by 331
SEEFF, L. B., WRIGHT, E. C., ZIMMERMAN, H. J., ALTER, H. J., DIETZ, A. A., FELSHER, B. F., FINKELSTEIN, J. D., GARCIA-PONT, P., GERIN, J. L., GREENLEE, H. B., et al. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-88-3-285 · Cited by 325
Hs, M. (1995) · JAMA · doi:10.1001/jama.274.15.1201 · Cited by 323
Bruce, M. G., Bruden, D., Hurlburt, D., Zanis, C., Thompson, G., Rea, L., Toomey, M., Townshend-Bulson, L., Rudolph, K., Bulkow, L., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv748 · Cited by 322
Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-up
McMahon, B. J., Bruden, D. L., Petersen, K. M., Bulkow, L. R., Parkinson, A. J., Nainan, O., Khristova, M., Zanis, C., Peters, H., & Margolis, H. S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00008 · Cited by 315
Hepatitis B and the Need for a Booster Dose
Leuridan, E., & Van Damme, P. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir270 · Cited by 308
Self-citationImmunogenicity of Hepatitis B vaccines
Averhoff, F., Mahoney, F., Coleman, P., Schatz, G., Hurwitz, E., & Margolis, H. (1998) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00003-8 · Cited by 275
Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination
Shaw, F. E., Guess, H. A., Roets, J. M., Mohr, F. E., Coleman, P. J., Mandel, E. J., Roehm, R. R., Talley, W. S., & Hadler, S. C. (1989) · Vaccine · doi:10.1016/0264-410x(89)90157-6 · Cited by 263
Hepatitis B Vaccine in Medical Staff of Hemodialysis Units: Efficacy and Subtype Cross-Protection
Szmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Alter, H. J., Taylor, P. E., DE Vera, A., Chen, G. T. S., Kellner, A., & the Dialysis Vaccine Trial Study Group (1982) · New England Journal of Medicine · doi:10.1056/nejm198212093072403 · Cited by 262
Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B
Chen, D.-S. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.002 · Cited by 261
Stevens, C. E. (1985) · JAMA · doi:10.1001/jama.1985.03350360066020 · Cited by 256
Seroepidemiology of Hepatitis B Virus Infection in Children: Ten Years of Mass Vaccination in Taiwan
Chen, H.-L. (1996) · JAMA · doi:10.1001/jama.1996.03540110060032 · Cited by 241
#38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission
Dionne-Odom, J., Tita, A. T. N., & Silverman, N. S. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.09.100 · Cited by 238
Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines
Zuckerman, J. N. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20524 · Cited by 223
Crosnier, J., Jungers, P., Couroucé, A., Laplanche, A., Benhamou, E., Degos, F., Lacour, B., Prunet, P., Cerisier, Y., & Guesry, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92679-9 · Cited by 214
Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory
Banatvala, J., Van Damme, P., & Oehen, S. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00224-3 · Cited by 213
Self-citationProgress towards hepatitis B prevention through vaccination in the Western Pacific, 1990–2014
Wiesen, E., Diorditsa, S., & Li, X. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.060 · Cited by 210
Schillie, S., Harris, A., Link-Gelles, R., Romero, J., Ward, J., & Nelson, N. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6715a5 · Cited by 208
Hepatitis B vaccine – do we need boosters?
Banatvala, J. E., & Van Damme, P. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00400.x · Cited by 207
Self-citationRoberts, H., Kruszon‐Moran, D., Ly, K. N., Hughes, E., Iqbal, K., Jiles, R. B., & Holmberg, S. D. (2016) · Hepatology · doi:10.1002/hep.28109 · Cited by 205
Funk, A. L., Lu, Y., Yoshida, K., Zhao, T., Boucheron, P., van Holten, J., Chou, R., Bulterys, M., & Shimakawa, Y. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30586-7 · Cited by 205
Xu, Z.-Y., Liu, C.-B., Francis, D. P., Purcell, R. H., Gun, Z.-L., Duan, S.-C., Chen, R.-J., Margolis, H. S., Huang, C.-H., Maynard, J. E., et al. (1985) · Pediatrics · doi:10.1542/peds.76.5.713 · Cited by 203
Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine
André, F. E. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90525-1 · Cited by 203
Minimization of hepatitis B infection by a 25-year universal vaccination program
Ni, Y.-H., Chang, M.-H., Wu, J.-F., Hsu, H.-Y., Chen, H.-L., & Chen, D.-S. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.021 · Cited by 202
Lu, C., Ni, Y., Chiang, B., Chen, P., Chang, M., Chang, L., Su, I., Kuo, H., Huang, L., Chen, D., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587695 · Cited by 198
Jackson, S., Lentino, J., Kopp, J., Murray, L., Ellison, W., Rhee, M., Shockey, G., Akella, L., Erby, K., Heyward, W. L., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2017.12.038 · Cited by 197
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases
Langer-Gould, A., Qian, L., Tartof, S. Y., Brara, S. M., Jacobsen, S. J., Beaber, B. E., Sy, L. S., Chao, C., Hechter, R., & Tseng, H. F. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2633 · Cited by 194
Vaccination against Hepatitis B: Comparison of Three Different Vaccination Schedules
Jilg, W., Schmidt, M., & Deinhardt, F. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/160.5.766 · Cited by 185
Lu, C., Chiang, B., Chi, W., Chang, M., Ni, Y., Hsu, H., Twu, S., Su, I., Huang, L., & Lee, C. (2004) · Hepatology · doi:10.1002/hep.20490 · Cited by 183
Protection Provided by Hepatitis B Vaccine in a Yupik Eskimo Population--Results of a 10-Year Study
Wainwright, R. B., Bulkow, L. R., Parkinson, A. J., Zanis, C., & McMahon, B. J. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.3.674 · Cited by 182
(1979) · Journal of Infection · doi:10.1016/s0163-4453(79)80018-3 · Cited by 182
Lee, L. A., Franzel, L., Atwell, J., Datta, S. D., Friberg, I. K., Goldie, S. J., Reef, S. E., Schwalbe, N., Simons, E., Strebel, P. M., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.11.035 · Cited by 181
Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants
FitzSimons, D., François, G., Hall, A., McMahon, B., Meheus, A., Zanetti, A., Duval, B., Jilg, W., Böcher, W. O., Lu, S.-N., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.03.017 · Cited by 178
Protective efficacy of hepatitis B vaccines in neonates
André, F. E., & Zuckerman, A. J. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890440206 · Cited by 172
Greenup, A.-J., Tan, P. K., Nguyen, V., Glass, A., Davison, S., Chatterjee, U., Holdaway, S., Samarasinghe, D., Jackson, K., Locarnini, S. A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.038 · Cited by 167
HAMMITT, L., HENNESSY, T., FIORE, A., ZANIS, C., HUMMEL, K., DUNAWAY, E., BULKOW, L., & MCMAHON, B. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.059 · Cited by 167
WELLS, M. A., WITTEK, A. E., EPSTEIN, J. S., MARCUS‐SEKURA, C., DANIEL, S., TANKERSLEY, D. L., PRESTON, M. S., & QUINNAN, G. V. (1986) · Transfusion · doi:10.1046/j.1537-2995.1986.26286152919.x · Cited by 161
LEGIONNAIRES' DISEASE RELATED TO GASTRIC LAVAGE WITH TAP WATER
Dournon, E., Bure, A., Desplaces, N., Carette, M. F., & Mayaud, C. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91837-2 · Cited by 161
Whittle, H., Jaffar, S. S., Wansbrough, M., Mendy, M., Dumpis, U., Collinson, A., & Hall, A. (2002) · BMJ · doi:10.1136/bmj.325.7364.569 · Cited by 156
Lamivudine in Late Pregnancy to Interrupt In Utero Transmission of Hepatitis B Virus
Shi, Z., Yang, Y., Ma, L., Li, X., & Schreiber, A. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181e45951 · Cited by 156
Hepatitis B vaccination in infancy in The Gambia: protection
Viviani, S., Jack, A., Hall, A. J., Maine, N., Mendy, M. E., Montesano, R., & Whittle, H. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00178-4 · Cited by 152
Mendy, M. E., Peterson, I., Hossin, S., Peto, T. J., Jobarteh, M. L., Jeng-Barry, A., Sidibeh, M., Jatta, A., Moore, S. E., Hall, A. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058029 · Cited by 150
Rottinghaus, S. T., Poland, G. A., Jacobson, R. M., Barr, L. J., & Roy, M. J. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00447-x · Cited by 147
Production and immunological analysis of recombinant hepatitis B vaccine
Emini, E. A., Ellis, R. W., Miller, W. J. W., McAleer, W. J., Scolnick, E. M., & Gerety, R. J. (1986) · Journal of Infection · doi:10.1016/s0163-4453(86)92563-6 · Cited by 147
Wong, R. J., Brosgart, C. L., Welch, S., Block, T., Chen, M. I.-C., Cohen, C. A., Kim, W. R., Kowdley, K. V., Lok, A. S.-F., Tsai, N. C. S., et al. (2021) · Hepatology · doi:10.1002/hep.31782 · Cited by 146
Coleman, P. J., McQuillan, G. M., Moyer, L. A., Lambert, S. B., & Margolis, H. S. (1998) · The Journal of Infectious Diseases · doi:10.1086/515696 · Cited by 143
Reilly, M., Sawyer, M., Hoerger, T. J., Murphy, T. V., Schillie, S., Hu, D. J., Spradling, P., Byrd, K., Xing, J., Tohme, R. A., et al. (2011) · Cited by 143
Outcomes of Infants Born to Women Infected With Hepatitis B
Schillie, S. F., Walker, T. Y., Veselsky, S. L., Crowley, S., Dusek, C., Lazaroff, J., Morris, S. A., Onye, K., Ko, S. C., Fenlon, N., et al. (2015) · PEDIATRICS · doi:10.1542/peds.2014-3213 · Cited by 142
Halperin, S. A., Ward, B. J., Cooper, C., Predy, G., Díaz‐Mitoma, F., Dionne, M., Embreé, J., McGeer, A., Zickler, P., Moltz, K.-H., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.087 · Cited by 140
Rendi‐Wagner, P., Shouval, D., Genton, B., Lurie, Y., Rümke, H. C., Boland, G. J., Cerny, A., Heim, M. H., Bach, D., Schroeder, M., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.01.007 · Cited by 139
Long‐Term Protection against Carriage of Hepatitis B Virus after Infant Vaccination
van der Sande, M. A. B., Waight, P., Mendy, M. E., Rayco‐Solon, P., Hutt, P., Fulford, T. J., Doherty, C. P., McConkey, S. J., Jeffries, D. J., Hall, A. J., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/503433 · Cited by 138
Halperin, S. A., Dobson, S., McNeil, S., Langley, J. M., Smith, B. R., McCall-Sani, R., Levitt, D., Nest, G. V., Gennevois, D., & Eiden, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.095 · Cited by 134
Mele, A., Tancredi, F., Romanò, L., Giuseppone, A., Colucci, M., Sangiuolo, A., Lecce, R., Adamo, B., Tosti, M. E., Taliani, G., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/323396 · Cited by 134
Le, M. H., Yeo, Y. H., Cheung, R. C., Henry, L. L., Lok, A. S.-F., & Nguyen, M. H. (2019) · Hepatology · doi:10.1002/hep.30831 · Cited by 133
The Increasing Burden of Imported Chronic Hepatitis B — United States, 1974–2008
Mitchell, T., Armstrong, G. L., Hu, D. J., Wasley, A., & Painter, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027717 · Cited by 132
The status of hepatitis B control in the African region
Breakwell, L., Tévi‐Bénissan, C., Childs, L., Mihigo, R., & Tohme, R. A. (2017) · Pan African Medical Journal · doi:10.11604/pamj.supp.2017.27.3.11981 · Cited by 131
Dentinger, C., McMahon, B. J., Butler, J. C., Dunaway, C. E., Zanis, C. L., BULKOW, L. R., Bruden, D. L., Nainan, O. V., Khristova, M. L., Hennessy, T. W., et al. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000176617.63457.9f · Cited by 126
Twelve-year follow-up study of hepatitis B immunization of Senegalese infants
Coursaget, P., Leboulleux, D., SOUMARÉ, M., Cann, P. L., Yvonnet, B., Jp, C., Coll-Seck, A.-M., & Diop‐Mar, I. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80404-0 · Cited by 124
Hurie, M. B., Mast, E. E., & Davis, J. P. (1992) · PEDIATRICS · doi:10.1542/peds.89.2.269 · Cited by 124
Liao, S., Li, R., Li, H., Yang, J.-Y., Zeng, X., Gong, J., Wang, S., Li, Y., & Zhang, K. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00031-6 · Cited by 123
Peto, T. J., Mendy, M. E., Lowe-Jallow, Y., Webb, E. L., Whittle, H. C., & Hall, A. J. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-7 · Cited by 123
Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000)
Beutels, P. (2001) · Health Economics · doi:10.1002/hec.625 · Cited by 122
Heyward, W. L., Kyle, M., Blumenau, J., Davis, M., Reisinger, K. S., Kabongo, M. L., Bennett, S. R., Janssen, R. S., Namini, H., & Martin, J. T. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.05.068 · Cited by 121
Bialek, S. R., Bower, W. A., Novak, R. T., Helgenberger, L., Auerbach, S. B., Williams, I. T., & Bell, B. P. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31817702ba · Cited by 120
Vaccination Coverage Among Children Aged 19–35 Months — United States, 2015
Hill, H. A., Elam-Evans, L. D., Yankey, D., Singleton, J. A., & Dietz, V. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6539a4 · Cited by 120
Jan, C.-F. J., Huang, K., Chien, Y.-C., Greydanus, D. E., Davies, D. H., Chiu, T., Huang, L., Chen, C., & Chen, D. (2010) · Hepatology · doi:10.1002/hep.23543 · Cited by 111
Long-term protection of hepatitis B vaccine 18 years after vaccination
Alfaleh, F., AlShehri, S., AlAnsari, S., et al. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.08.008 · Cited by 111
Cassidy, W. M., Watson, B. M., Ioli, V. A., Williams, K., Bird, S. R., & West, D. J. (2001) · PEDIATRICS · doi:10.1542/peds.107.4.626 · Cited by 109
Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents
Gabbuti, A., Romanò, L., Blanc, P., Meacci, F., Amendola, A., Mele, A., Mazzotta, F., & Zanetti, A. R. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.045 · Cited by 109
Samandari, T., Fiore, A. E., Negus, S., Williams, J. L., Kuhnert, W., McMahon, B. J., & Bell, B. P. (2007) · Pediatrics · doi:10.1542/peds.2007-0131 · Cited by 108
Boxall, E. H., Sira, J., El‐Shuhkri, N., & Kelly, D. A. (2004) · The Journal of Infectious Diseases · doi:10.1086/423818 · Cited by 108
Posuwan, N., Wanlapakorn, N., Sa-nguanmoo, P., Wasitthankasem, R., Vichaiwattana, P., Klinfueng, S., Vuthitanachot, V., Sae-lao, S., Foonoi, M., Fakthongyoo, A., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150499 · Cited by 107
Prevention of Vertical Transmission of Hepatitis B
Kubo, A., Shlager, L., Marks, A. R., Lakritz, D., Beaumont, C., Gabellini, K., & Corley, D. A. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2529 · Cited by 106
Seroprotection after recombinant hepatitis B vaccination among newborn infants: A review
Schillie, S. F., & Murphy, T. V. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.12.012 · Cited by 105
Huang, L.-M., Chiang, B.-L., Lee, C.-Y., Lee, P.-I., Chi, W.-K., & Chang, M.-H. (1999) · Hepatology · doi:10.1002/hep.510290349 · Cited by 104
Hepatitis B immunization: vaccine types, efficacy, and indications for immunization.
Sc, H., & Margolis, H. S. (1992) · PubMed · Cited by 104
Simons, B. C., Spradling, P. R., Bruden, D. J. T., Zanis, C., Case, S., Choromanski, T. L., Apodaca, M., Brogdon, H. D., Dwyer, G., Snowball, M., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw142 · Cited by 101
Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders
Stratton, K. R., Gable, A. R., & Mc, M. (2001) · Cited by 101
The worldwide impact of vaccination on the control and protection of viral hepatitis B
Romanò, L., Paladini, S., Damme, P. V., & Zanetti, A. R. (2010) · Digestive and Liver Disease · doi:10.1016/s1590-8658(10)60685-8 · Cited by 98
Williams, I. T., Goldstein, S. T., Tufa, J., TAUILLII, S., Margolis, H. S., & Mahoney, F. J. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000050463.28917.25 · Cited by 97
Economic Evaluation of Vaccination Programmes
Beutels, P., Edmunds, W. J., anzas, F. A., de Wit, G. A., Evans, D., Feilden, R., Fendrick, A. M., Ginsberg, G. M., Glick, H. A., Mast, E. E., et al. (2002) · PharmacoEconomics · doi:10.2165/00019053-200220010-00001 · Cited by 96
Hepatitis B vaccine by intradermal route in non responder patients: An update
Filippelli, M., Lionetti, E., Gennaro, A., Lanzafame, A., Arrigo, T., Salpietro, C., Rosa, M. L., & Leonardi, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10383 · Cited by 93
DiMiceli, L. E., Pool, V., Kelso, J. M., Shadomy, S. V., Iskander, J., & V.A.E.R.S. Team (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.069 · Cited by 93
van der Sande, M. A. B., Waight, P. A., Mendy, M. E., Zaman, S. M. A., Kaye, S., Sam, O., Kahn, A., Jeffries, D. J., Aveika, A. A., Hall, A. J., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000753 · Cited by 93
Yusuf, H. R. (2000) · JAMA · doi:10.1001/jama.284.8.978 · Cited by 92
Mikaeloff, Y., Caridade, G., Assi, S., Tardieu, M., Suissa, S., & on behalf of the KIDSEP study group of the French Neuropaediatric Society (2006) · Brain · doi:10.1093/brain/awl368 · Cited by 91
Su, F., Cheng, S., Li, C., Chen, J. ‐., Hsiao, C.-Y., Chien, C., Yang, Y.-C., Hung, H.-H., & Chu, F. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.09.013 · Cited by 90
Status of hepatitis B immunization programmes in 1998
KANE, M. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00308-9 · Cited by 90
Development and production aspects of a recombinant yeast-derived hepatitis B vaccine
Stéphenne, J. (1990) · Vaccine · doi:10.1016/0264-410x(90)90221-7 · Cited by 89
Hepatitis B vaccination: A completed schedule enough to control HBV lifelong?
Fitzsimons, D. W., Hendrickx, G., Vorsters, A., & Damme, P. V. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.101 · Cited by 88
Self-citationEvaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines
Zuckerman, J. N., Zuckerman, A. J., Symington, I. S., Du, W., Williams, A. H., Dickson, B., & Young, M. D. (2001) · Hepatology · doi:10.1053/jhep.2001.27564 · Cited by 86
Grading of recommendations assessment, development and evaluation( GRADE)
Pacheco, C. (2012) · Contacto Científico · Cited by 86
Determinants of Long-term Protection After Hepatitis B Vaccination in Infancy: A Meta-analysis
Schönberger, K., Riedel, C., Rückinger, S., Mansmann, U., Jilg, W., & von Kries, R. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31827bd1b0 · Cited by 83
But, D. Y.-K., Lai, C., Lim, W.-L., Fung, J., Wong, D. K.-H., & Yuen, M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.034 · Cited by 83
Childs, L., Roesel, S., & Tohme, R. A. (2018) · Vaccine · doi:10.1016/j.vaccine.2017.11.027 · Cited by 82
Janssen, R. S., Mangoo‐Karim, R., Pérgola, P. E., Girndt, M., Namini, H., Rahman, S., Bennett, S. R., Heyward, W. L., & Martin, J. T. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.05.067 · Cited by 81
Hepatitis B Therapy in Pregnancy
Bzowej, N. H. (2010) · Current Hepatology Reports · doi:10.1007/s11901-010-0059-x · Cited by 79
Antiviral Therapy for Chronic Hepatitis B in Pregnancy
Lee, H. M., & Pan, C. Q. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1345718 · Cited by 79
Viviani, S., Carrieri, P., Bah, E., Hall, A. J., Kirk, G. D., Mendy, M. E., Montesano, R., Plymoth, A., Sam, O., van der Sande, M. A. B., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0303 · Cited by 77
Shockey, T. M., Luckhaupt, S. E., Groenewold, M. R., & Lu, M. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6701a1 · Cited by 73
Cooper, C., & Mackie, D. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.162 · Cited by 72
Zhu, C., Liu, P., Chen, T., Ni, Z., Lu, L., Huang, F., Lu, J., Sun, Z., & Qu, C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.098 · Cited by 69
Duval, B., Gîlca, V., Boulianne, N., et al. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000154329.00361.39 · Cited by 69
Poovorawan, Y., Chongsrisawat, V., Theamboonlers, A., Crasta, P. D., Messier, M., & Hardt, K. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24844 · Cited by 68
Safety of immunisation and adverse events following vaccination against hepatitis B
DUCLOS, P. J. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.3.225 · Cited by 66
A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults
Marsano, L. S., West, D. J., Chan, I. S. F., Hesley, T. M., Cox, J., Hackworth, V., & Greenberg, R. N. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00233-8 · Cited by 64
Woodring, J., Pastore, R., Brink, A., Ishikawa, N., Takashima, Y., & Tohme, R. A. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6808a2 · Cited by 62
Hepatitis B control by 2012 in the WHO Western Pacific Region:
Rani, M. (2009) · Bulletin of the World Health Organization · doi:10.2471/blt.08.059220 · Cited by 61
Ding, L., Zhang, M., Wang, Y., et al. (1993) · PubMed · Cited by 60
Goldfarb, J., Baley, J. E., MEDENDORP, S. V., Seto, D. S. Y., GARCIA, H., Toy, P. T. C. Y., Watson, B. M., GOOCH, M. W., & KRAUSE, D. (1994) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199401000-00005 · Cited by 59
Agerton, T., Mahoney, F. J., Polish, L. B., & Shapiro, C. N. (1995) · Infection Control and Hospital Epidemiology · doi:10.1086/647109 · Cited by 59
Kao, J., Wang, J., Hung, C., Yen, Y., Hung, S., Hu, T., Lee, C., & Lu, S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.027 · Cited by 59
Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults
Bruguera, M., Bayas, J. M., Vilella, A., Tural, C., González, A., Vidal, J., Dal-Ré, R., & Salleras, L. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00089-8 · Cited by 58
Hepatitis B Vaccine Administered to Children and Adolescents at Yearly Intervals
Halsey, N. A., Moulton, L. H., O'Donovan, J. C., Walcher, J., THOMS, M. L., Margolis, H. S., & Krause, D. S. (1999) · PEDIATRICS · doi:10.1542/peds.103.6.1243 · Cited by 57
Gîlca, V., Serres, G. D., Boulianne, N., Murphy, D. G., Wals, P. D., Ouakki, M., Trudeau, G., Massé, R., & Dionne, M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.037 · Cited by 55
Old and new adjuvants for hepatitis B vaccines
Leroux-Roels, G. G. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0375-9 · Cited by 54
The impact of hepatitis B vaccine in China and in the China GAVI Project
Hadler, S. C., Fuqiang, C., Averhoff, F. M., Taylor, T. H., Wang, F., Li, L., Xiaofeng, L., & Weizhong, Y. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.03.043 · Cited by 54
Duffell, E. F., Hedrich, D., Mårdh, O., & Mozalevskis, A. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.9.30476 · Cited by 54
Wu, Q., Zhuang, G., Wang, X., Wang, L., Li, N., & Zhang, M. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.025 · Cited by 52
Cui, F., Luo, H., Wang, F., Zheng, H., Gong, X.-H., Chen, Y., Wu, Z., Miao, N., Kane, M., Hennessey, K. A., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.11.061 · Cited by 51
Littlejohn, M., Davies, J., Yuen, L. K. W., Edwards, R., Sozzi, T., Jackson, K., Cowie, B., Tong, S. Y. C., Davis, J. S., & Locarnini, S. (2014) · Journal of Medical Virology · doi:10.1002/jmv.23888 · Cited by 48
Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study
Spada, E., Romanò, L., Tosti, M. E., Zuccaro, O., Paladini, S., Chironna, M., Coppola, R., Cuccia, M., Mangione, R., Marrone, F., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12591 · Cited by 48
The long‐term efficacy of plasma‐derived hepatitis B vaccine in babies born to carrier mothers
Young, B. W., Lee, S. S., Lim, W. L., & Yeoh, E. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00386.x · Cited by 46
Poovorawan, Y., Chongsrisawat, V., Theamboonlers, A., Srinivasa, K., Hutagalung, Y., Bock, H. L., & Hoet, B. (2009) · The Journal of Infectious Diseases · doi:10.1086/599331 · Cited by 45
Janssen, J. M., Jackson, S., Heyward, W. L., & Janssen, R. S. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.070 · Cited by 43
Economic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug Users
Hu, Y., Grau, L. E., Scott, G., Seal, K. H., Marshall, P. A., Singer, M. C., & Heimer, R. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.03.028 · Cited by 41
Janssen, J. M., Heyward, W. L., Martin, J. T., & Janssen, R. S. (2015) · Vaccine · doi:10.1016/j.vaccine.2014.12.060 · Cited by 40
West, D. J., Hesley, T. M., Jonas, L., FEELEY, L. K., Bird, S. R., Burke, P., & SADOFF, J. C. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199706000-00010 · Cited by 39
Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study
Yu, O., Bohlke, K., Hanson, C. A., Delaney, K. M., Rees, T. G., Zavitkovsky, A., Ray, P., Mullooly, J. P., BLACK, S. B., Benson, P. J., et al. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1354 · Cited by 39
Duration and Efficacy of Immune Response to Hepatitis B Vaccine in High-Risk Chinese Adolescents
Mintai, Z., Kezhou, L., Lieming, D., & Smego, R. A. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/16.1.165 · Cited by 38
Rubio, J. D.-D., Dal‐Ré, R., Llorente, M., González, A., & López, J. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00049-2 · Cited by 37
Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles
Rajkannan, R., Dhanaraju, M. D., Damodaran, G., Selvaraj, D., & Rajadas, J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.011 · Cited by 36
Induced immunity against hepatitis B virus
Said, Z. N. A., & Abdelwahab, K. S. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i12.1660 · Cited by 35
Postexposure Effects of Vaccines on Infectious Diseases
Gallagher, T., & Lipsitch, M. (2019) · Epidemiologic Reviews · doi:10.1093/epirev/mxz014 · Cited by 35
Kosinska, A. D., Liu, J., Lu, M., & Roggendorf, M. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0379-5 · Cited by 33
Wang, F., Shen, L., Cui, F., Zhang, S., Zheng, H., Zhang, Y., Liang, X., Wang, F., & Bi, S. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.064 · Cited by 27
Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations
Rosenthal, E. M., Hall, E. W., Rosenberg, E. S., Harris, A. M., Nelson, N. P., & Schillie, S. F. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.10.067 · Cited by 27
Michel, M., Bourgine, M., Fontaine, H., & Pol, S. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0381-y · Cited by 26
Allison, R. D., Teleb, N. A., Awaidy, S. T. A., Ashmony, H., Alexander, J. P., & Patel, M. K. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.063 · Cited by 24
ANTIBODY RESPONSES OF HEALTHY NEONATES TO TWO MIXED REGIMENS OF HEPATITIS B VACCINE
Seto, D. S. Y., West, D. J., Gilliam, R. R., Ioli, V. A., Ferrara, D. K., & Rich, B. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199909000-00025 · Cited by 19
Twenty Years of Universal Vaccination against Hepatitis B in Italy: Achievements and Challenges
Romanò, L., Paladini, S., & Zanetti, A. R. (2012) · Journal of Public Health Research · doi:10.4081/jphr.2012.e18 · Cited by 18
Cited by
Jeng, W.-J., Papatheodoridis, G. V., & Lok, A. S. F. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01468-4 · Cited by 561
Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease
Nelson, N. P., Easterbrook, P. J., & McMahon, B. J. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.06.006 · Cited by 366
Vaccines to Prevent Infections by Oncoviruses
Schiller, J. T., & Lowy, D. R. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134019 · Cited by 101
Metadata
- Authors
- Pattyn, J., Hendrickx, G., Vorsters, A., & Van Damme, P.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-09-30
- Volume
- 224
- Issue
- Supplement_4
- Pages
- S343-S351
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W3203496295
- Cited by
- 282
- References
- 175
- FWCI
- 10.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.